For metastatic melanoma patients receiving anti-PD-1-based immunotherapy, gut bacterial species more abundant in responders include Bifidobacterium longum, Collinsella aerofaciens, and Enterococcus faecium [5]. The gene discussed is PDCD1; the disease is metastatic melanoma.